Peter Høngaard Andersen, M.D., M.Sc. Scient.
Executive Vice President
Lundbeck Research
H. Christian Fibiger, Ph.D.
Chief Scientific Officer and SVP
Biovail Laboratories International SRL
Michael Lytton
EVP, Corporate and Business Development
Biogen Idec
David Michelson, M.D.
VP, Clinical Neuroscience and Ophthalmology
Merck Research Laboratories
J. Anthony Ware, MD
Vice President-Lilly Research Laboratories GBD Platform Leader-Diabetes/Cardiovascular/Acute Care
Eli Lilly and Company
Gary Gabrielsen
Vice President of Business Development
Astellas US LLC
Sandy Retsky
Global Business Development
Wyeth
Dr. Joern-Peter Halle
Vice President Early Stage Licensing
Portfolio Development Merck Serono
Jeff Hanke
Vice President, Cancer Research
AstraZeneca |
Betsy Garofalo M.D.
Global Therapeutic Area Leader, CNS
Astellas
Jeremy Levin, M.D., Ph.D.
Senior Vice President, Strategic Transactions
Bristol-Myers Squibb
Anna Protopapas
Senior Vice President and Head, Corporate Development and Strategy
Millennium: The Takeda Oncology Company
Charles Wilson
Vice President, Global Head of Strategic Alliances
Novartis Institutes for BioMedical Research
Peter Wirth
Executive Vice President, Legal and Corporate Development
Genzyme Corporation
Dr. Susan Rohrer
Senior Director, External Science Affairs
Merck and Company
Dr JC Gutierrez-Ramos
SVP and Head, Immuno-Inflammation Centre of Excellence for Drug Discovery
Glaxosmithkline
Dr. Michele Mercuri
VP, Acting Head of the Dept. of Cardiovascular Medicine, Global Development
Daiichi Sankyo |